Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Operating Leases (2018 - 2025)

Health Catalyst (HCAT) has disclosed Operating Leases for 8 consecutive years, with $15.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases fell 5.29% year-over-year to $15.1 million, compared with a TTM value of $15.1 million through Sep 2025, down 5.29%, and an annual FY2024 reading of $16.3 million, down 22.55% over the prior year.
  • Operating Leases was $15.1 million for Q3 2025 at Health Catalyst, down from $15.9 million in the prior quarter.
  • Across five years, Operating Leases topped out at $23.1 million in Q1 2021 and bottomed at $15.1 million in Q3 2025.
  • Average Operating Leases over 5 years is $18.7 million, with a median of $18.6 million recorded in 2022.
  • The sharpest move saw Operating Leases skyrocketed 1578.76% in 2021, then dropped 22.55% in 2024.
  • Year by year, Operating Leases stood at $20.2 million in 2021, then grew by 5.96% to $21.5 million in 2022, then fell by 1.94% to $21.0 million in 2023, then dropped by 22.55% to $16.3 million in 2024, then fell by 7.16% to $15.1 million in 2025.
  • Business Quant data shows Operating Leases for HCAT at $15.1 million in Q3 2025, $15.9 million in Q2 2025, and $15.8 million in Q1 2025.